Latest Research

K Sharma et al, 2022. Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson's disease according to task demands, Psychopharmacology, published online.

C Kositamongkol et al 2021. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis, Frontiers in Pharmacology, published online.

K Mehlig et al, 2021. Associations between alcohol and liver enzymes are modified by coffee, cigarettes, and overweight in a Swedish female population, Scandinavian Journal of Gastroenterology, published online.

S Niezen et al, 2021. Coffee consumption is associated with lower liver stiffness: a nationally representative study, Clinical Gastroenterology and Hepatology, in Press.

M Ebadi et al, 2021. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies, Nutrients, Volume 13 (9).

N F Lange et al, 2021. Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention, Journal of Hepatology, published online.

O J Kennedy at al, 2021. All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study, BMC Public Health, Volume 21 Article 970.

J Chhimwal et al, 2021. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink, Clinical Nutrition, Volume 40 (1).

C Lammert et al, 2021. Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption, Dig Dis Sci, published online.

I Mikolasevic et al, Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis: controlled attenuation parameter and liver stiffness measurements, International Journal of Clinical Practice, published online.

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.